<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Elghobary MEN</submitter><funding>Japan Society for the Promotion of Science</funding><pagination>1864</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9962004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(4)</volume><pubmed_abstract>Auger electrons (AEs) are very low-energy electrons emitted by radionuclides such as I-125 (&lt;sup>125&lt;/sup>I). This energy is deposited across a small distance (&lt;0.5 μm), resulting in high linear energy transfer that is potent for causing lethal damage to cancer cells. Thus, AE-emitting radiotherapeutic agents have great potential for cancer treatment. In this study, thermosensitive liposomes (TSLs) encapsulating &lt;sup>125&lt;/sup>I-labeled doxorubicin (DOX) derivatives were developed for Auger electron therapy, targeting the DNA of cancer cells. A radioiodinated DOX derivative [&lt;sup>125&lt;/sup>I]&lt;b>5&lt;/b> highly accumulated in the nuclei of cancer cells and showed potent cytotoxicity against Colon 26 cancer cells by AEs. Subsequently, [&lt;sup>125&lt;/sup>I]&lt;b>5&lt;/b> was loaded into the TSLs with high e</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy.</pubmed_title><pmcid>PMC9962004</pmcid><funding_grant_id>22K07812</funding_grant_id><pubmed_authors>Mishiro K</pubmed_authors><pubmed_authors>Ogawa K</pubmed_authors><pubmed_authors>Fuchigami T</pubmed_authors><pubmed_authors>Elghobary MEN</pubmed_authors><pubmed_authors>Munekane M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy.</name><description>Auger electrons (AEs) are very low-energy electrons emitted by radionuclides such as I-125 (&lt;sup>125&lt;/sup>I). This energy is deposited across a small distance (&lt;0.5 μm), resulting in high linear energy transfer that is potent for causing lethal damage to cancer cells. Thus, AE-emitting radiotherapeutic agents have great potential for cancer treatment. In this study, thermosensitive liposomes (TSLs) encapsulating &lt;sup>125&lt;/sup>I-labeled doxorubicin (DOX) derivatives were developed for Auger electron therapy, targeting the DNA of cancer cells. A radioiodinated DOX derivative [&lt;sup>125&lt;/sup>I]&lt;b>5&lt;/b> highly accumulated in the nuclei of cancer cells and showed potent cytotoxicity against Colon 26 cancer cells by AEs. Subsequently, [&lt;sup>125&lt;/sup>I]&lt;b>5&lt;/b> was loaded into the TSLs with high e</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T08:53:07.172Z</modification><creation>2025-04-04T08:53:07.172Z</creation></dates><accession>S-EPMC9962004</accession><cross_references><pubmed>36838851</pubmed><doi>10.3390/molecules28041864</doi></cross_references></HashMap>